Investigating the causes for decreased levels of glutathione in individuals with type II diabetes

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lagman, Minette ^a   Ly, Judy ^a   Saing, Tommy ^a   Singh, Manpreet Kaur ^a   Tudela, Enrique Vera ^a   Morris, Devin ^a   Chi, Po Ting ^a   Ochoa, Cesar ^b   Sathananthan, Airani ^b   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Western Diabetes Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC SUBUNIT OF GLUTAMINE CYSTEINE LIGASE; CD14 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LIGASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANAZOLENE SODIUM; CYTOKINE; FUCHSINE;

ADULT; AGED; ARTICLE; BACTERIAL SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; GLUTATHIONE METABOLISM; GRANULOMA; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; BLOOD; DEFICIENCY; DIABETES MELLITUS; DISEASE PREDISPOSITION; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; TUBERCULOSIS; WESTERN BLOTTING;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; BLOTTING, WESTERN; CYTOKINES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-17; INTERLEUKIN-6; MACROPHAGES; MIDDLE AGED; REACTIVE OXYGEN SPECIES; ROSANILINE DYES; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 84925425892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118436     Document Type: Article

References (38)

1. Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, et al. (2011) Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ 89: 352-359. doi: 10.2471/BLT.10.085738 PMID: 21556303
2. World Health Organization (2014) Tuberculosis [Fact sheet].
3. World Health Organization (2011) Tuberculosis & Diabetes [Fact sheet].
4. American Diabetes Association (2013) Data and Statistics about Diabetes [Fact sheet].
5. Center for Disease Control (2014) National Diabetes Statistics Report [Brochure].
6. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert Committee. Diabetes Care 32: e159; author reply e160. doi: 10.2337/dc09-1231 PMID: 19940222
7. World Health Organization (2011) Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. [Abbreviated Report].
8. Gan YH (2013) Host susceptibility factors to bacterial infections in type 2 diabetes. PLoS Pathog 9: e1003794. doi: 10.1371/journal.ppat.1003794 PMID: 24385898
9. Tan KS, Lee KO, Low KC, Gamage AM, Liu Y, et al. (2012) Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest 122: 2289-2300. doi: 10.1172/JCI57817 PMID: 22546856
10. Oni T, Stoever K, Wilkinson RJ (2013) Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority. Lancet Respir Med 1: 356-358. doi: 10.1016/S2213-2600(13)70116-4 PMID: 24429192
11. Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14: S233-236. PMID: 12874437
12. Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, et al. (2013) Glutathione and infection. Biochim Biophys Acta 1830: 3329-3349. doi: 10.1016/j.bbagen.2012.10.012 PMID: 23089304
13. Griffith OW (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27: 922-935. PMID: 10569625
14. Franklin CC, Rosenfeld-Franklin ME, White C, Kavanagh TJ, Fausto N (2003) TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J 17: 1535-1537. PMID: 12824300
15. Bakin AV, Stourman NV, Sekhar KR, Rinehart C, Yan X, et al. (2005) Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med 38: 375-387. PMID: 15629866
16. Orlowski M, Meister A (1970) The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A 67: 1248-1255. PMID: 5274454
17. Alkozai EM, Lisman T, Porte RJ, NijstenMW(2014) Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival. F1000Res 3: 85. doi: 10.12688/f1000research.3316.1 PMID: 25075298
18. Zhang H, Forman HJ, Choi J (2005) Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol 401: 468-483. PMID: 16399403
19. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, et al. (2006) Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55: 928-934. PMID: 16784966
20. Wieser V, Moschen AR, Tilg H (2013) Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) 61: 119-125. doi: 10.1007/s00005-012-0210-1 PMID: 23307037
21. Lee YJ, Heo JS, Suh HN, Lee MY, Han HJ (2007) Interleukin-6 stimulates alpha-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-kappaB. Am J Physiol Renal Physiol 293: F1036-1046. PMID: 17581928
22. Venketaraman V, Dayaram YK, Talaue MT, Connell ND (2005) Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis. Infect Immun 73: 1886-1889. PMID: 15731094
23. Venketaraman V, Dayaram YK, Amin AG, Ngo R, Green RM, et al. (2003) Role of glutathione in macrophage control of mycobacteria. Infect Immun 71: 1864-1871. PMID: 12654802
24. Guerra C, Morris D, Sipin A, Kung S, Franklin M, et al. (2011) Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS One 6: e28378. doi: 10.1371/journal.pone.0028378 PMID: 22164280
25. Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V (2008) Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. J Interferon Cytokine Res 28: 153-165. doi: 10.1089/jir.2007.0095 PMID: 18338948
26. Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, et al. (2008) Glutathione levels and immune responses in tuberculosis patients. Microb Pathog 44: 255-261. PMID: 17959342
27. Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, et al. (2013) Glutathione supplementation improves macrophage functions in HIV. J Interferon Cytokine Res 33: 270-279. doi: 10.1089/jir.2012.0103 PMID: 23409922
28. Cilfone NA, Perry CR, Kirschner DE, Linderman JJ (2013) Multi-scale modeling predicts a balance of tumor necrosis factor-alpha and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection. PLoS One 8: e68680. doi: 10.1371/journal.pone.0068680 PMID: 23869227
29. Roca FJ, Ramakrishnan L (2013) TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153: 521-534. doi: 10.1016/j.cell.2013.03.022 PMID: 23582643
30. Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, et al. (2011) Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35: 1023-1034. doi: 10.1016/j.immuni.2011.12.002 PMID: 22195750
31. Liu PT, Modlin RL (2008) Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 20: 371-376. doi: 10.1016/j.coi.2008.05.014 PMID: 18602003
32. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 184: 3326-3330. doi: 10.4049/jimmunol.0904189 PMID: 20200276
33. Tobin DM, Roca FJ, Ray JP, Ko DC, Ramakrishnan L (2013) An enzyme that inactivates the inflammatory mediator leukotriene b4 restricts mycobacterial infection. PLoS One 8: e67828. doi: 10.1371/journal.pone.0067828 PMID: 23874453
34. Cousens L, Orange JS, Biron CA (1995) Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. Journal of Immunology: 5690-5699.
35. Lai YP, Lin CC, Liao WJ, Tang CY, Chen SC (2009) CD4+ T cell-derived IL-2 signals during early priming advances primary CD8+ T cell responses. PLoS One 4: e7766. doi: 10.1371/journal.pone.0007766 PMID: 19901991
36. Alam K, Ghousunnissa S, Nair S, Valluri VL, Mukhopadhyay S (2010) Glutathione-redox balance regulates c-rel-driven IL-12 production in macrophages: possible implications in antituberculosis immunotherapy. J Immunol 184: 2918-2929. doi: 10.4049/jimmunol.0900439 PMID: 20164428
37. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C (1998) Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95: 3071-3076. PMID: 9501217
38. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146. PMID: 12563297